您当前的位置：
首页 >
文章列表页 >
Network meta-analysis of the efficacy and safety of immune checkpoint inhibitors in first-line treatment of advanced gastric cancer
更新时间：2026-02-11

    • Network meta-analysis of the efficacy and safety of immune checkpoint inhibitors in first-line treatment of advanced gastric cancer

    • “The latest research focuses on the first-line treatment of advanced gastric cancer. Experts found through a network meta-analysis that Cadoni_Chemo and SHR-1701_Chemo perform well in prolonging the median overall survival and progression free survival of patients, and have significant advantages in patients with PD-L1 CPS score ≥ 5, providing new ideas for the treatment of advanced gastric cancer.”
    • ZHONGGUO YAOFANG   Vol. 37, Issue 3, Pages: 383-388(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.03.19    

      CLC： R735.2;R979.1

    • Received：24 September 2025，

      Revised：2026-01-27，

      Accepted：28 January 2026，

      Published：15 February 2026

    移动端阅览

  • KE Liyuan,WANG Yan,WANG Anping,et al.Network meta-analysis of the efficacy and safety of immune checkpoint inhibitors in first-line treatment of advanced gastric cancer[J].ZHONGGUO YAOFANG,2026,37(03):383-388. DOI： 10.6039/j.issn.1001-0408.2026.03.19.

  •  
  •  

0

Views

3

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Pharmaceutical care for a case of severe dermal toxicity induced by durvalumab
伊立替康单药与联合消癌平治疗老年晚期胃癌的比较研究
卡培他滨联合顺铂对晚期胃癌患者疗效及胃癌细胞侵袭转移的影响
贝伐珠单抗联合化疗方案用于晚期胃癌的临床观察
紫杉醇、奥沙利铂联合榄香烯腹腔灌注治疗胃癌晚期癌性腹水的临床观察

Related Author

GU Pingchen
LIU Tingting
YAO Lijuan
LIU Lili
DENG Xiaowen
LIU Pengcheng
QIN Zhengbi
JI Liulian

Related Institution

Dept. of Oncology， Yancheng Second People’s Hospital
Dept. of Humanities and Medical Ethics， School of Medicine， Hubei Minzu University
School of International Pharmaceutical Business， China Pharmaceutical University
Yancheng Food and Drug Inspection Center （Adverse Drug Reaction Monitoring Center）
Dept. of Pharmacy， Yancheng Second People’s Hospital
0